Recent News for THAR - Tharimmune, Inc.

Date	Title
Feb 5	Tharimmune Announces Dosing of First Patient in Phase 1 Clinical Trial of TH104, its Lead Candidate for Pruritus in Primary Biliary Cholangitis
Jan 29	Tharimmune Announces Initiation of Phase 1 Clinical Trial of TH104 and Provides Business Update